Mr. Loos, what motivation do you, participate in the InnovationLabworkshop "Organ-onChip" as representative of the life Science cluster bioRN and moderator of the panel discussion in Heidelberg present to to be there?
Friedemann Loos: Meine Motivation liegt darin, die neuesten Entwicklungen und Anwendungen der Organ‒on‒Chip ‒Technologie zu diskutieren und zu fördern. Diese Technologie hat das Potenzial, die Art und Weise, wie wir Krankheiten modellieren und Medikamente entwickeln, zu revolutionieren.
You are molecular biologist, expert in life sciences and networker. Why is the topic OoC from your comprehensive perspective just now so relevant?
Loos: This technology makes it possible to replicate complex physiological processes on microchips, which leads to more accurate and faster results in drug development and disease modeling. It also offers an ethical alternative to animal testing and supports personalized medical approaches.